Calendar Marker Therapeutics, Inc.

Equities

MRKR

US57055L2060

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 21:00:00 13/02/2026 GMT			5-day change	1st Jan Change
1.430 ^USD	-0.69%		-13.33%	-4.03%

11-13	Marker Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
11-03	Marker Therapeutics, Inc. Announces Data from Phase 1 APOLLO Study to Present in Two Posters at 67Th American Society of Hematology Annual Meeting and Exposition	CI

Chart calendar Marker Therapeutics, Inc.

0c1.YvnraoBtw6kRgxCepVpbi-Lbsco8C7ewpJC4fN2YrbM.J7qTOLc8iMhjwED_8Cg9ws-a5vNrM_2AkuqKS-n87p49ztMB01-yy3zWSQ~f518146bf28f05a90a6f222b13c70640

Upcoming events on Marker Therapeutics, Inc.

11/03/2026	Q4 2025 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
19/05/2026	Q1 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
11/11/2026	Q3 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
18/05/2027	Q1 2027 Earnings Release (Projected)	Add to your calendar Google Apple ICS format

Past events on Marker Therapeutics, Inc.

08/12/2025	American Society of Hematology Meeting
06/12/2025	American Society of Hematology Meeting
14/11/2025	Q3 2025 Earnings Release
10/09/2025	H.C. Wainwright Global Investment Conference
26/08/2025	Business Update Call
12/08/2025	Canaccord Genuity Growth Conference
06/06/2025	Annual General Meeting
03/06/2025	Investor Meeting
28/05/2025	Investor Meeting - Key Opinion Leaders
14/05/2025	Q1 2025 Earnings Release
07/04/2025	Canaccord Genuity Horizons in Oncology Virtual Conference
31/03/2025	Q4 2024 Earnings Release
20/03/2025	Extraordinary Shareholders Meeting
25/02/2025	H.C. Wainwright Cell Therapy Virtual Conference
12/12/2024	Ladenburg Thalmann & Co. Virtual Oncology Innovators & Investors Symposium
02/12/2024	Citizens JMP Hematology and Oncology Summit
14/11/2024	Q3 2024 Earnings Release
06/06/2024	Annual General Meeting
15/05/2024	Q1 2024 Earnings Release
01/04/2024	Hematologic Malignancies Global Summit

Annual results

Fiscal Period	December	2022	2023	2024	2025	2026	2027
Net sales Million USD	Released Forecast Spread	9,01 9,00 0.15%	0,00	6,59 8,32 -20.79%	3,10	2,70	19,5
EBITDA Million USD	Released Forecast Spread	0,00 0,00 -	0,00	-11,1 -9,68 -14.91%	-14,4	-16,7	-16,0
EBIT Million USD	Released Forecast Spread	0,00 0,00 -	0,00	-11,1 -7,90 -40.8%	-14,6	-24,3	-22,3
Earnings before Tax (EBT) Million USD	Released Forecast Spread	0,00 0,00 -	-14,0	-10,7 -7,43 -43.76%	-13,8	-23,9	-22,3
Net income Million USD	Released Forecast Spread	0,00 0,00 -	-8,24	-10,7 -7,40 -45.06%	-13,8	-24,0	-19,9
EPS USD	Released Forecast Spread	-3,58 -3,60 0.56%	0,00	-1,19 -0,73 -63.01%	-0,94	-1,44	-0,95
Announcement Date		22/03/23	25/03/24	31/03/25	-

Quarterly results

Fiscal Period	September	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4
Net sales Million USD	Released Forecast Spread	1,24 0,00 -	1,17 0,00 -	1,93 1,00 92.6%	2,25 3,98 -43.45%	0,35 0,00 -	0,86 0,72 19.11%	1,23 0,72 70.53%	0,68	0,60	0,60	0,60	0,60
EBITDA Million USD	Released Forecast Spread				-3,86 -2,42 -59.63%		-4,26 -3,18 -34.16%	-2,14 -3,18 32.72%	-3,39	-4,10	-5,10	-5,20	-5,40
EBIT Million USD	Released Forecast Spread	-2,55 -2,45 -4.21%	-2,31 -3,98 42.07%	-2,40 -3,52 31.82%	-3,86 -3,20 -20.78%	-4,61 -7,00 34.16%	-4,26 -4,64 8.13%	-2,14 -6,34 66.29%	-3,63	-4,10	-5,10	-5,20	-5,40
Earnings before Tax (EBT) Million USD	Released Forecast Spread	-2,39 -2,26 -6.02%	-2,31 -3,86 40.14%	-2,31 -3,43 32.76%	-3,79 -3,09 -22.74%	-4,45 -6,90 35.56%	-4,02 -4,53 11.31%	-2,00 -6,28 68.16%	-3,29	-3,90	-4,90	-5,00	-5,20
Net income Million USD	Released Forecast Spread	-2,39 -2,26 -6.02%	-2,19 -3,86 43.14%	-2,31 -3,43 32.76%	-3,84 -3,09 -24.36%	-4,45 -7,10 37.38%	-4,02 -4,58 12.28%	-2,00 -6,38 68.66%	-3,32	-3,90	-4,90	-5,00	-5,20
EPS USD	Released Forecast Spread	-0,27 -0,25 -8%	-0,25 -0,43 41.86%	-0,26 -0,39 33.33%	-0,42 -0,22 -90.91%	-0,40 -0,66 39.39%	-0,29 -0,41 29.27%	-0,12 -0,45 73.33%	-0,20	-0,22	-0,27	-0,27	-0,21
Announcement Date		15/05/24	14/08/24	14/11/24	31/03/25	15/05/25	14/08/25	13/11/25	-	-	-	-	-

Upcoming sector events for Marker Therapeutics, Inc.

16/02/2026	BASILEA PHARMACEUTICA AG	Q4 2025 Earnings Release	Add to your calendar Google Apple ICS format
18/02/2026	BIOARCTIC AB	Q4 2025 Earnings Release	Add to your calendar Google Apple ICS format
18/02/2026	CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	Q4 2025 Earnings Release	Add to your calendar Google Apple ICS format
18/02/2026	AMICUS THERAPEUTICS, INC.	Q4 2025 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
18/02/2026	RELAY THERAPEUTICS, INC.	Q4 2025 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
18/02/2026	INTELLIA THERAPEUTICS, INC.	Q4 2025 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
18/02/2026	KYMERA THERAPEUTICS, INC.	Q4 2025 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
18/02/2026	PRAXIS PRECISION MEDICINES, INC.	Q4 2025 Earnings Release	Add to your calendar Google Apple ICS format
18/02/2026	GRAIL, INC.	Q4 2025 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
19/02/2026	TELIX PHARMACEUTICALS LIMITED	Q4 2025 Earnings Release	Add to your calendar Google Apple ICS format

More events

Past sector events for Marker Therapeutics, Inc.

12/02/2026	BRIGHT MINDS BIOSCIENCES INC.	Q1 2026 Earnings Release
12/02/2026	GNI GROUP LTD.	Q4 2025 Earnings Release
12/02/2026	TAKARA BIO INC.	Q3 2025 Earnings Release
12/02/2026	CRISPR THERAPEUTICS AG	Q4 2025 Earnings Release
11/02/2026	BLUEPRINT MEDICINES CORPORATION	Q4 2025 Earnings Release (Projected)
11/02/2026	ASCENDIS PHARMA A/S	Q4 2025 Earnings Release
10/02/2026	SUNMAX BIOTECHNOLOGY CO., LTD.	January 2026 Sales and Revenue Release
10/02/2026	POLARIS GROUP	January 2026 Sales and Revenue Release
10/02/2026	PELL BIO-MED TECHNOLOGY CO., LTD.	January 2026 Sales and Revenue Release
09/02/2026	MEDPACE HOLDINGS, INC.	Q4 2025 Earnings Release